Global
circulating tumor cells market is expected to reach USD 2.28 billion by 2020.
Growing prevalence of cancer has heightened the need for effective and early
diagnosis. Circulating tumor cells cater to this heightened need and are
therefore, expected to witness a surge in demand during the forecast period.
Majority of cancer deaths are due to circulating tumor cells and an early
diagnosis of the same is expected to increase survival rates. Targeted therapy
in cancer has large untapped opportunities and therefore, entails extensive
R&D investments aimed at new product development. However, high procedure
costs and lack of commercialized products are expected to impede market growth
during the forecast period.
Further key findings from the study
suggest:
Tumor
cell detection was the leading product segment in 2013 primarily owing to the
advantages associated with therapeutic monitoring and high procedure prices.
Its market is expected to reach an estimated value of over USD 250.0 million by
2020.
Molecular
technique emerged as the largest tumor cell detection segment in 2013. This
technique holds several advantages over optical tumor cell detection technique
and therefore, witnesses higher usage rates. Notable advantages of molecular
tumor cell detection techniques include higher sensitivity and high-throughput
analysis. Moreover, the introduction of new products such as CellSearch by
Janssen Pharmaceutical is expected to drive segment growth.
Tumor
cell enrichment is also expected to witness lucrative growth over the next six
years. The market is primarily driven by rapidly growing demand for prognostic
technologies coupled with the presence of high patient unmet needs.
Immunological
and immunomagnetic techniques associated with tumor cell enrichment were the
largest market in 2013, accounting for a share of over 50.0%. It is the most
commonly used diagnostic technique and therefore, hold high market penetration
rates.
North
America was the most revenue generating market in 2013. Presence of
sophisticated healthcare infrastructure, growing prevalence of cancer and
relatively larger presence of commercialized products are some factors
attributing to its market position.
Related reports by Radiant Insights: http://www.radiantinsights.com/catalog/biotechnology
The
Asia Pacific circulating tumor cells market holds lucrative future growth
opportunities. High prevalence of unmet patient needs, constantly improving
healthcare infrastructure and increasing healthcare expenditure levels in the
emerging markets of India and China are some factors accounting for its market
attractiveness.
Some
key players of the circulating tumor cells market include AVIVA BioSciences
Corporation, Silicon Biosystems S.p.A, Advanced Cell Diagnostics Inc, Celula
Inc., Epic Sciences Inc., AdnaGen AG, Vitatex Inc, Rarecells Inc. and Fluxion
Biosciences Inc.
Table of Contents
Chapter
1. Executive Summary
1.1. Circulating Tumor Cells - Industry Summary
and Critical Success Factors (CSFs)
Chapter
2. Circulating Tumor Cells Industry
Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Circulating Tumor Cells Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Circulating Tumor Cells Market PESTEL
Analysis, 2013
See More Reports of This Category
by Radiant Insights:
·
South Korea Respiratory Disposables Market Outlook
to 2021 - http://www.radiantinsights.com/research/south-korea-respiratory-disposables-market-outlook-to-2021
·
Russia Respiratory Disposables Market Outlook to
2021 - http://www.radiantinsights.com/research/russia-respiratory-disposables-market-outlook-to-2021
Chapter
3. Circulating Tumor Cells Technology
Outlook
3.1. Market Estimates and Forecasts, 2012 - 2020
(USD Million)
3.2. Tumor Cell Enrichment Technology
3.2.1. Market Estimates and
Forecasts, 2012 - 2020 (USD Million)
3.2.2.Filtration Market Estimates
and Forecasts, 2012 - 2020 (USD Millio)
3.2.3.Centrifugation Market
Estimates and Forecasts, 2012 - 2020 (USD Million)
3.2.4.Immunological and
Immunomagnetic Market Estimates and Forecasts, 2012 - 2020 (USD Million)
About Radiant Insights
Radiant
Insights is a platform for companies looking to meet their market research and
business intelligence requirements. We assist and facilitate organizations and
individuals procure market research reports, helping them in the decision making
process. We have a comprehensive collection of reports, covering over 40 key
industries and a host of micro markets. In addition to over extensive database
of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
For More Information, Visit Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog URL: http://www.radiantinsightsinc.blogspot.com
No comments:
Post a Comment